• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale

by Fred Pennic 10/30/2020 Leave a Comment

Mammoth Lands 2 Partnerships to Use CRISPR to Solve COVID19 Testing Shortage

What You Should Know:

– Mammoth Biosciences signs agreements with MilliporeSigma and Hamilton company targeting commercialization of high-throughput CRISPR-based SARS CoV-2 Test.

– These partnerships will help Mammoth bring a turnkey CRISPR-based sample-to-answer solution for commercial laboratories to enable a multi-fold increase in a testing capacity.


Mammoth Biosciences, Inc., announced that it has signed agreements with MilliporeSigma and Hamilton Company targeting commercialization of a high-throughput CRISPR-based SARS CoV-2 test. The test leverages Mammoth’s DETECTR BOOST™ platform and will provide a sample-to-answer turnkey solution for commercial laboratories to enable a multi-fold increase in testing capacity. 

As laboratories nationwide face limited capacity and testing supply shortages amid the pandemic, Mammoth Biosciences is poised to help reduce the backlog by working with leading manufacturing and automation vendors for its CRISPR-based SARS-CoV-2 molecular assay. The high-throughput systems will be compatible with both nasal swab and saliva samples and are targeting 1500 tests per 8-hour shift with minimal user interaction. Mammoth Biosciences plans to submit the assay for FDA Emergency Use Authorization later this year.

“In order to begin reopening more aspects of society, we’ll need a robust testing infrastructure that can rapidly scale up capacity as needed,” said Trevor Martin, Ph.D., co-founder and CEO of Mammoth Biosciences. “By combining CRISPR-based diagnostics with the proven manufacturing and product leadership of MilliporeSigma and Hamilton Company, we’re confident this solution will be a game-changer for labs.” 

Mammoth’s DETECTR BOOST™ SARS-CoV-2 assay reagent kits, which will be contract manufactured by MilliporeSigma, rival PCR in sensitivity while being less prone to supply chain risk. The testing system will also leverage standard, automated liquid handling equipment such as those from Hamilton Company to enable rapid processing of patient samples. By implementing this unique offering, CLIA laboratories will be able to significantly improve their capacity to regularly test communities and businesses in need. 

“This collaboration will allow us to help Mammoth with the development and production of their new SARS-CoV-2 test, which, once approved by the FDA, will increase testing capacity here in the U.S. at the scale needed to combat this pandemic,” said Jean-Charles Wirth, head of Applied Solutions at MilliporeSigma. “MilliporeSigma is helping to advance the future of testing at scale. This is an important step in detecting Covid-19 quickly.”

RELATED:   How COVID-19 Reshaped Healthcare Consumerism & 4 Key Trends to Know for 2021

Tagged With: Coronavirus (COVID-19)

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies
Fern Health Taps 10M Mass General De-Identified Patient Records for Pain Management »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    ... more
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment

    West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution

    ... more
  • Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    ... more
  • op 5 business opportunities for digital health companies in 2021. Where is the money?

    Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 22 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • op 5 business opportunities for digital health companies in 2021. Where is the money? Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |